David Parrot
Chief Financial Officer, Scribe Therapeutics, Inc.
Companies
- Scribe Therapeutics, Inc.Chief financial officer Jul 23, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Scribe Therapeutics, Inc. SCTX1,333 shares2$27.9K at $20.93Jul 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 23, 2026Bought 1,333 shares at $15.00 of Scribe Therapeutics, Inc.2
- Jul 23, 2026Bought 1,333 shares at $15.00 of Scribe Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2